Electro Diagnostic Equipment Market to Rise at 8.7% CAGR during Forecast Period 2023-2030, Data By Contrive Datum Insights
Contrive Datum Insights Pvt Ltd
Contrive Datum Insights Pvt Ltd

According to a market research study published by Contrive Datum Insights, North America is expected to maintain its dominant position in the electrodiagnostic equipment industry, Asia is expected to develop at the fastest pace because of the large domestic customer population

Farmington, March 19, 2023 (GLOBE NEWSWIRE) -- The Global Electro Diagnostic Equipment Market Size Is Expected At USD 1,354.2 Million In 2022, Expanding At A CAGR 8.7% From 2022-2030. Researchers use electrodiagnostic (EDX) equipment to measure how nerves and muscles use electricity. The information that comes out of the diagnosis helps doctors and therapists figure out how to treat conditions like neuropathy, myopathy, plexopathy, and disorders of the neuromuscular junction. Electrodiagnostic testing includes two special tests: Electromyography (EMG) and Nerve Conduction Studies. (NCS). Nerve conduction studies, or NCS, look at how nerves work by sending small electrical pulses through electrodes that are connected to the skin. Electromyography (EMG) is a test in which small needle electrodes are put into different muscles to measure the electrical activity of the muscles.

Request Sample Copy of Report “Electro Diagnostic Equipment Market - Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2022 to 2030”, published by Contrive Datum Insights.

Electro Diagnostic Equipment Market Recent Developments:

  • In December 2021, GE announced the completion of its previously announced acquisition of BK Medical, a leader in progressive surgical visualization, from Altaris Capital Partners, LLC. The companies have reached a definitive agreement for GE to acquire BK Medical for his $1.45 billion cash purchase price on September 22, 2021. Equipped with pre- and post-operative ultrasound capabilities, we develop end-to-end products through the complete continuum of care from diagnosis to treatment and beyond.

  • In August 2021, Nihon Kohden acquired Advanced Medical Predictive Devices, Diagnostics, and Display (AMP3D) for an undisclosed amount. AMP3D offers an extensive set of clinical prediction algorithms and software as a service (SaaS) platform. The company's CoMET (Continuous Monitoring of Event Trajectory) decision support software utilizes patient continuous monitoring data, vital signs, medical records and laboratory tests to provide real-time and ongoing risk trajectories for patients. indicate.

  • In May 2019, Nihon Kohden announced the introduction of the Neuropack S3 electrodiagnostic (EDX) system, a progressive multimodality platform for neurodiagnostic procedures. Highlighting the company's latest-generation amplifier and signal processing technology, the Neuropack S3 is expected to deliver high-quality his EDX surveys while also reducing its footprint and improving portability. The Neuropack S3 system was established to be versatile enough for both hospital and private practice applications to perform electromyography, nerve conduction studies, evoked potentials, and additional diagnostic procedures.